Media coverage about Castlight Health (NYSE:CSLT) has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Castlight Health earned a coverage optimism score of 0.17 on Accern’s scale. Accern also assigned news articles about the software maker an impact score of 45.6488903203992 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the media stories that may have effected Accern’s analysis:
Castlight Health (NYSE:CSLT) opened at $3.65 on Friday. The stock has a market cap of $494.82, a PE ratio of -7.60 and a beta of 1.57. The company has a current ratio of 1.94, a quick ratio of 1.94 and a debt-to-equity ratio of 0.03. Castlight Health has a 52-week low of $3.05 and a 52-week high of $4.75.
CSLT has been the topic of a number of research reports. Cantor Fitzgerald reaffirmed a “hold” rating and set a $5.00 target price on shares of Castlight Health in a research report on Wednesday, October 25th. Chardan Capital lowered their price target on shares of Castlight Health from $6.50 to $6.30 and set a “buy” rating on the stock in a report on Thursday, October 26th. Zacks Investment Research lowered shares of Castlight Health from a “buy” rating to a “hold” rating in a report on Monday, January 1st. BidaskClub downgraded shares of Castlight Health from a “sell” rating to a “strong sell” rating in a research note on Thursday, November 9th. Finally, Canaccord Genuity restated a “buy” rating and issued a $7.00 target price on shares of Castlight Health in a research note on Thursday, October 26th. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $5.11.
In other news, CEO John C. Doyle sold 13,686 shares of the company’s stock in a transaction dated Friday, November 17th. The stock was sold at an average price of $3.71, for a total value of $50,775.06. Following the completion of the sale, the chief executive officer now directly owns 123,705 shares of the company’s stock, valued at approximately $458,945.55. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Mangini Siobhan Nolan sold 8,866 shares of the company’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $3.70, for a total value of $32,804.20. Following the completion of the sale, the chief financial officer now directly owns 78,561 shares of the company’s stock, valued at $290,675.70. The disclosure for this sale can be found here. In the last quarter, insiders have sold 22,778 shares of company stock worth $84,411. 37.43% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: This news story was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/04/castlight-health-cslt-receives-media-impact-score-of-0-17.html.
Castlight Health Company Profile
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.